LifeMD (NASDAQ:LFMD) Now Covered by Cantor Fitzgerald
Equities research analysts at Cantor Fitzgerald assumed coverage on shares of LifeMD (NASDAQ:LFMD – Get Free Report) in a research note issued to investors on Friday, MarketBeat Ratings reports. The brokerage set an “overweight” rating and a $7.00 price target on the stock. Cantor Fitzgerald’s price objective indicates a potential upside of 98.30% from the […]